Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

10. Segment and Geographic Information (Details) - USD ($)	3 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Revenues	$ 4,711,000	$ 4,369,000
Product [Member]
Revenues	4,385,000	4,095,000
Product [Member] \| UNITED STATES
Revenues	2,487,000	1,971,000
Product [Member] \| Latin America [Member]
Revenues	654,000	1,079,000
Product [Member] \| Europe and Rest of the World [Member]
Revenues	$ 1,244,000	$ 1,045,000